• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR CP ANTI-HBS2 (AHBS2) ASSAY; AHBS2 IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR CP ANTI-HBS2 (AHBS2) ASSAY; AHBS2 IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problem No Apparent Adverse Event (3189)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/27/2019
Event Type  malfunction  
Manufacturer Narrative
The cause for the discordant (b)(6) results is unknown.Siemens healthcare diagnostics is investigating.
 
Event Description
A false reactive advia centaur cp (b)(6) result was obtained for a patient sample.The sample was repeated since the (b)(6) result was reactive.The (b)(6)was reactive.The patient sample was sent out to another branch using the advia centaur xp and tested for (b)(6).The (b)(6) results were nonreactive and the (b)(6) results were reactive.The customer reported (b)(6) result as nonreactive.It is unknown if patient treatment was prescribed or altered.There was no report of adverse health consequences due to the (b)(6) results.
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2019-00146 on august 1, 2019.08/07/2019 additional information: patient treatment was not prescribed or altered.The type of blood collection tube that was used was serum, bd vaccutainer.Siemens is awaiting further information from the customer.
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2019-00146 on (b)(6) 2019.Siemens filed the mdr 1219913-2019-00146 supplemental report 1 on (b)(6) 2019.(b)(6)2019 additional information: siemens has requested the advia centaur xp ahbs2 lot number that was used to test the sample at the pathlab singapore from the customer.The response received was no lot information was provided.(b)(6)2019 additional information: the customer had a sample that recovered repeat reactive (22.64, 21.23 miu/ml) with advia centaur cp anti-hbs2 (ahbs2) lot 102 but was nonreactive when tested with an advia centaur xp at another lab.The sample was hbsag reactive at the customer's lab and the other lab.They believe the nonreactive ahbs2 result.The customer was not able to provide the patient's medical status or a list of medications/supplements the patient is taking.There is no sample that can be sent to siemens for evaluation.The relative sensitivity and specificity section of the advia centaur cp anti-hbs2 instructions for use (ifu) (10629924, revision j, 2017-12) lists the 95% confidence interval (ci) for resolved relative specificity as 98.34% - 99.88% so a certain number of false positive results can be expected for this assay.This one false positive result does not indicate a product problem with advia centaur cp ahbs2 lot 102.The cause of the false positive results seen by the customer with this one sample when using advia centaur cp ahbs2 lot 102 could not be determined but siemens cannot rule out pre-analytical factors, a sample issue, or normal assay performance.Based on the investigation, no product problem was identified.The instrument is performing within specifications.No further evaluation of the device is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR CP ANTI-HBS2 (AHBS2) ASSAY
Type of Device
AHBS2 IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
MDR Report Key8850217
MDR Text Key152941142
Report Number1219913-2019-00146
Device Sequence Number1
Product Code LOM
UDI-Device Identifier00630414561790
UDI-Public00630414561790
Combination Product (y/n)N
PMA/PMN Number
P100039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 09/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/01/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/21/2020
Device Model NumberN/A
Device Catalogue Number10286268
Device Lot Number102
Was Device Available for Evaluation? No
Date Manufacturer Received08/28/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-